MOS vs TRDA · P/E 161, rev $11.12B vs P/E 12, rev $210.8M
The Mosaic Company (MOS) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
MOS currently screens at market cap $7.15B and trailing P/E 160.8. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the MOS and TRDA stock pages for the full models.
Not investment advice.